click below
click below
Normal Size Small Size show me how
BDK: ENDOCRINE 2
25-26 LIST
| GENERIC | BRAND | CATEGORY | INDICATION | SIDE EFFECTS | BOXED WARNINGS | NOTES |
|---|---|---|---|---|---|---|
| drospirenone and ethinyl estradiol | Yasmin 28, Yaz | Contraceptive | Contraception, Acne | nausea, changes in menstrual flow, breast tenderness, thromboembolic disorders, headache, weight gain | increased risk of cardiovascular events in women >35 years old who smoke | CI in hepatic dysfunction, thromboembolic disorders, breast cancer, migraines with aura, and cardiovascular disease |
| levonorgestrel and ethinyl estradiol | Lutera, Levora, Seasonique | Contraceptive | Contraception, Acne | nausea, changes in menstrual flow, breast tenderness, thromboembolic disorders, headache, weight gain | increased risk of cardiovascular events in women >35 years old who smoke | CI in hepatic dysfunction, thromboembolic disorders, breast cancer, migraines with aura, and cardiovascular disease |
| norethindrone and ethinyl estradiol | Junel, Loestrin, Microgestin | Contraceptive | Contraception, Acne | nausea, changes in menstrual flow, breast tenderness, thromboembolic disorders, headache, weight gain | increased risk of cardiovascular events in women >35 years old who smoke | CI in hepatic dysfunction, thromboembolic disorders, breast cancer, migraines with aura, and cardiovascular disease |
| norethindrone, ethinyl estradiol, and ferrous fumarate | Lo Loestrin Fe, Microgestin Fe | Contraceptive | Contraception, Acne | nausea, changes in menstrual flow, breast tenderness, thromboembolic disorders, headache, weight gain | increased risk of cardiovascular events in women >35 years old who smoke | CI in hepatic dysfunction, thromboembolic disorders, breast cancer, migraines with aura, and cardiovascular disease |
| norgestimate and ethinyl estradiol | Tri-Sprintec, Sprintec | Contraceptive | Contraception, Acne | nausea, changes in menstrual flow, breast tenderness, thromboembolic disorders, headache, weight gain | increased risk of cardiovascular events in women >35 years old who smoke | CI in hepatic dysfunction, thromboembolic disorders, breast cancer, migraines with aura, and cardiovascular disease |
| norgestrel and ethinyl estradiol | Crysell-28, Low-Ogestrel | Contraceptive | Contraception, Acne | nausea, changes in menstrual flow, breast tenderness, thromboembolic disorders, headache, weight gain | increased risk of cardiovascular events in women >35 years old who smoke | CI in hepatic dysfunction, thromboembolic disorders, breast cancer, migraines with aura, and cardiovascular disease |
| etrogens, conjugated (equine) | Premarin | Estrogen derivative | Vasomotor symptoms associated with menopause, vaginal atrophy associated with menopause | irritation at application site (transdermal patch only), edema, abdominal pain, breast tenderness, weight gain, thromboembolic disorders (myocardial infarction, stroke, VTE) | increased risk of breast cancer; should not be used for dementia prevention; increased risk of endometrial cancer if not used concomitantly with progestin in women with a uterus; should not be used for prevention of cardiovascular disease | CI in hepatic dysfunction, thromboembolic disorders, cardiovascular disease, breast cancer, and estrogen-dependent tumor |
| estradiol (transdermal) | Climera, Vivelle Dot | Estrogen derivative | Vasomotor symptoms associated with menopause, vaginal atrophy associated with menopause | irritation at application site (transdermal patch only), edema, abdominal pain, breast tenderness, weight gain, thromboembolic disorders (myocardial infarction, stroke, VTE) | increased risk of breast cancer; should not be used for dementia prevention; increased risk of endometrial cancer if not used concomitantly with progestin in women with a uterus; should not be used for prevention of cardiovascular disease | CI in hepatic dysfunction, thromboembolic disorders, cardiovascular disease, breast cancer, and estrogen-dependent tumor |
| estradiol (PO) | Estrace | Estrogen derivative | Vasomotor symptoms associated with menopause, vaginal atrophy associated with menopause | irritation at application site (transdermal patch only), edema, abdominal pain, breast tenderness, weight gain, thromboembolic disorders (myocardial infarction, stroke, VTE) | increased risk of breast cancer; should not be used for dementia prevention; increased risk of endometrial cancer if not used concomitantly with progestin in women with a uterus; should not be used for prevention of cardiovascular disease | CI in hepatic dysfunction, thromboembolic disorders, cardiovascular disease, breast cancer, and estrogen-dependent tumor |
| medroxyprogesterone | Provera | Progestin | Abnormal uterine bleeding, secondary amenorrhea | acne, abnormal menstrual bleeding, headache, amenorrhea, weight gain | increased risk of breast cancer; should not be used for dementia prevention; should not be used for prevention of cardiovascular disease | CI in thromboembolic disorders, cardiovascular disease, estrogen or progesterone-dependent tumors, undiagnosed abnormal genital bleeding, hepatic impairment |